Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65
Launched by UNIVERSITY OF GRAZ · Dec 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a new type of exercise equipment called BioStrength, compared to traditional strength training machines, on muscle strength and overall fitness in adults aged 30 to 65. Over 12 weeks, participants will either use the BioStrength machines or conventional gym equipment to see which one helps improve muscle strength and body composition more effectively. The researchers will measure things like how strong participants are when doing exercises like leg and chest presses, as well as other physical fitness indicators.
To join the study, participants should be healthy adults aged between 30 and 65, with less than six months of experience in strength training. They should be willing to commit to the 12-week program and be able to perform basic strength exercises. However, individuals with certain health conditions, like heart disease or arthritis, or those who are pregnant, won't be eligible to participate. This trial is a great opportunity for those looking to improve their muscle strength and fitness in a structured environment while contributing to valuable research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Age between 30 and 65 years
- • Healthy individuals without significant medical conditions
- • Less than 6 months of prior strength training experience
- • Willing and able to participate in a 12-week training program
- • Capable of performing strength training exercises such as leg press and chest press
- • Able to provide written informed consent
- Exclusion Criteria:
- • • History of coronary heart disease
- • History of stroke
- • Need for changes in antihypertensive treatment within 3 months prior to study start
- • Arthritis
- • Pregnancy or less than three months postpartum
- • Pain and movement restrictions
- • Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics)
- • Any medical condition preventing participation in planned endurance and strength training
About University Of Graz
The University of Graz, a leading research institution in Austria, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university brings together experts from diverse fields to address pressing health challenges. Its state-of-the-art facilities and dedication to ethical research practices ensure the highest standards of participant safety and scientific integrity. By fostering a dynamic environment for clinical investigation, the University of Graz aims to translate research findings into meaningful healthcare solutions that benefit the wider community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leibnitz, Styria, Austria
Patients applied
Trial Officials
Martin Atia
Principal Investigator
University of Graz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported